Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | June 02, 2026 | June 04, 2026 |
| Lucira Health, Inc.LHDX · Entity 115613 | Director | June 01, 2022 | June 03, 2022 |
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 05, 2025 | June 10, 2025 |
| Silk Road Medical IncSILK · Entity 87417 | Director · President and CEO | March 02, 2021 | September 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,054 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 33,054 F1: Represents restricted stock units ("RSUs"). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
Lucira Health, Inc.
Report date June 01, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2032-05-31 | Direct | 59,459 |
Reported balance
After 2022-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-01 · Grant · Acquired 59,459 · Balance 59,459 F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting.
Sight Sciences, Inc.
Report date June 05, 2025 · Filed June 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,352 |
Reported balance
After 2025-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-05 · Grant · Acquired 30,952 · Balance 175,352 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $130,000 divided by the closing price of the Common Stock on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2: Includes (i) 44,400 shares of Common Stock, (ii) 30,952 RSUs, which are subject to vesting as reported herein, and (iii) 100,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 5, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $130,000 divided by the closing price of the Common Stock on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2: Includes (i) 44,400 shares of Common Stock, (ii) 30,952 RSUs, which are subject to vesting as reported herein, and (iii) 100,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 5, 2025.
Silk Road Medical Inc
Report date March 02, 2021 · Filed September 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 267,988 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Sale · Disposed 1,651 · Balance 267,988 F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2: This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2: This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2021 Filed Apr 14, 2021 20:02 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 395 | $1.60 | $632.00 |
DisclosureSEC source: 0001593968-21-001114 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-000917 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,862 Underlying: Common Stock · 11,000 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $52.96 | $582,518.20 |
DisclosureSEC source: 0001593968-21-000917 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $52.49 to $53.86. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 18:14 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-000917 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| March 02, 2021 Filed Sep 29, 2023 18:00 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 1,651 | $56.62 | $93,477.80 |
DisclosureSEC source: 0001593968-23-001343 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,988 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2 · price: This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:27 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantOption (right to buy) · Derivative | 46,100 | $0.00 Strike: $55.30 | $0.00 |
DisclosureSEC source: 0001593968-21-000744 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,100 Underlying: Common Stock · 46,100 shares Expires 2031-03-01 F5 · derivative.exercise_date: One forty-eighth of the shares subject to the option shall vest on April 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:27 UTC | Silk Road Medical Inc SILK · Entity 87417 | Tax withholdingCommon Stock | 1,692 | $56.75 | $96,021.00 |
DisclosureSEC source: 0001593968-21-000744 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,616 F2 · kind: The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F3 · shares: Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 20:27 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 21,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-000744 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,308 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2022 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 19:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-000466 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,862 Underlying: Common Stock · 11,000 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 19:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $59.55 | $655,057.70 |
DisclosureSEC source: 0001593968-21-000466 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $58.86 to $60.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 19:38 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-000466 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 21:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-21-000134 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,862 Underlying: Common Stock · 11,000 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 21:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $59.66 | $656,290.80 |
DisclosureSEC source: 0001593968-21-000134 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $59.03 to $60.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 21:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.60 | $17,600.00 |
DisclosureSEC source: 0001593968-21-000134 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 2,428 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · derivative · entry 7 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,862 Underlying: Common Stock · 2,428 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 8,572 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · derivative · entry 6 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,738 Underlying: Common Stock · 8,572 shares Expires 2024-12-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 2,428 | $58.35 | $141,677.44 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · nonDerivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $57.49 to $59.86. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 2,428 | $1.60 | $3,884.80 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 8,572 | $58.35 | $500,189.06 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $57.49 to $59.86. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 18:16 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 8,572 | $1.46 | $12,515.12 |
DisclosureSEC source: 0001593968-20-002359 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 20:22 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 11,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001593968-20-002196 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,310 Underlying: Common Stock · 11,000 shares Expires 2024-12-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 20:22 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 11,000 | $63.44 | $697,820.20 |
DisclosureSEC source: 0001593968-20-002196 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. F2 · price: This transaction was executed in multiple trades at price ranging from $62.13 to $64.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 20:22 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 11,000 | $1.46 | $16,060.00 |
DisclosureSEC source: 0001593968-20-002196 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 18:11 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 20,044 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001593968-20-002028 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,310 Underlying: Common Stock · 20,044 shares Expires 2024-12-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 18:11 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 20,044 | $66.16 | $1,326,133.09 |
DisclosureSEC source: 0001593968-20-002028 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $65.51 to $66.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 18:11 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 20,044 | $1.46 | $29,264.24 |
DisclosureSEC source: 0001593968-20-002028 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 3,194 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · derivative · entry 10 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,194 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 476 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · derivative · entry 9 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,194 Underlying: Common Stock · 476 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 16,374 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · derivative · entry 8 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,354 Underlying: Common Stock · 16,374 shares Expires 2024-12-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 3,194 | $60.98 | $194,780.34 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 6 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $60.04 to $61.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 3,194 | $1.38 | $4,407.72 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 5 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 476 | $60.98 | $29,028.00 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $60.04 to $61.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 476 | $1.38 | $656.88 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 16,374 | $60.98 | $998,538.92 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $60.04 to $61.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 18:17 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 16,374 | $1.46 | $23,906.04 |
DisclosureSEC source: 0001593968-20-001878 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 19:01 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 20,044 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001737 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,670 Underlying: Common Stock · 20,044 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 19:01 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 20,044 | $51.42 | $1,030,616.38 |
DisclosureSEC source: 0001593968-20-001737 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $50.53 to $52.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 19:01 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 20,044 | $1.38 | $27,660.72 |
DisclosureSEC source: 0001593968-20-001737 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 19:26 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 20,044 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001636 · primary_01.xml · derivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,714 Underlying: Common Stock · 20,044 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 19:26 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 20,044 | $45.42 | $910,442.58 |
DisclosureSEC source: 0001593968-20-001636 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $43.54 to $46.49. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 19:26 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 20,044 | $1.38 | $27,660.72 |
DisclosureSEC source: 0001593968-20-001636 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:40 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 20,044 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001459 · primary_01.xml · derivative · entry 5 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,758 Underlying: Common Stock · 20,044 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F5 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:40 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 20,044 | $37.29 | $747,440.76 |
DisclosureSEC source: 0001593968-20-001459 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,921 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $36.19 to $38.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:40 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 20,044 | $1.38 | $27,660.72 |
DisclosureSEC source: 0001593968-20-001459 · primary_01.xml · nonDerivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| May 20, 2020 Filed Jun 12, 2020 18:40 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 687 | $30.91 | $21,235.17 |
DisclosureSEC source: 0001593968-20-001459 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,608 F3 · kind: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:04 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 19,186 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001158 · primary_01.xml · derivative · entry 7 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,802 Underlying: Common Stock · 19,186 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:04 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionOption (right to buy) · Derivative | 858 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001593968-20-001158 · primary_01.xml · derivative · entry 6 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,988 Underlying: Common Stock · 858 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F4 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:04 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 19,186 | $37.63 | $721,963.42 |
DisclosureSEC source: 0001593968-20-001158 · primary_01.xml · nonDerivative · entry 4 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,921 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $37.13 to $38.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:04 UTC | Silk Road Medical Inc SILK · Entity 87417 | Exercise / conversionCommon Stock | 19,186 | $1.38 | $26,476.68 |
DisclosureSEC source: 0001593968-20-001158 · primary_01.xml · nonDerivative · entry 3 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. Read SEC document |
| May 11, 2020 Filed May 13, 2020 18:04 UTC | Silk Road Medical Inc SILK · Entity 87417 | SaleCommon Stock | 858 | $37.63 | $32,286.28 |
DisclosureSEC source: 0001593968-20-001158 · primary_01.xml · nonDerivative · entry 2 Rogers Erica J. · CIK 0001769940 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,921 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2019. F2 · price: This transaction was executed in multiple trades at price ranging from $37.13 to $38.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.